Jing Ping
Wenzhou, 325006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Functional near-infrared spectroscopy-guided neurofeedback combined with art therapy and cognitive behavioral therapy for post-stroke depression: A randomized controlled trial.
Journal: Journal of affective disorders
Published: October 22, 2025
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia.
Journal: CNS drugs
Published: November 27, 2023
Validation of a modified Chinese-language version of the Davos Assessment of Cognitive Biases Scale (MCL-DACOBS) in a sample of Chinese patients with schizophrenia.
Journal: Brain and behavior
Published: March 28, 2023
Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions.
Journal: Schizophrenia (Heidelberg, Germany)
Published: March 27, 2023
Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment: Evidence from a pilot study.
Journal: Journal of affective disorders
Published: March 11, 2023
Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale.
Journal: Frontiers in psychiatry
Published: February 04, 2023
Low-dose lithium mono- and adjunctive therapies improve MK-801-induced cognitive impairment and schizophrenia-like behavior in mice - Evidence from altered prefrontal lobe Ca2+ activity.
Journal: Journal of affective disorders
Published: January 24, 2023
Validity and reliability of a Chinese version of the self-evaluation of negative symptoms.
Journal: Brain and behavior
Published: November 15, 2022
Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder.
Journal: Frontiers in psychiatry
Published: August 05, 2022
Higher benefit-risk ratio of COVID-19 vaccination in patients with schizophrenia and major depressive disorder versus patients with bipolar disorder when compared to controls.
Journal: American journal of translational research
Published: March 01, 2022
Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target.
Journal: Translational psychiatry
Published: February 12, 2022
Brain Neural Activity Patterns in an Animal Model of Antidepressant-Induced Manic Episodes.
Journal: Frontiers in behavioral neuroscience
Published: September 09, 2021
Last Updated: 09/26/2026